CN106668030A - 一种猫流泪红肿药丸的制备方法 - Google Patents
一种猫流泪红肿药丸的制备方法 Download PDFInfo
- Publication number
- CN106668030A CN106668030A CN201611157398.5A CN201611157398A CN106668030A CN 106668030 A CN106668030 A CN 106668030A CN 201611157398 A CN201611157398 A CN 201611157398A CN 106668030 A CN106668030 A CN 106668030A
- Authority
- CN
- China
- Prior art keywords
- parts
- cat
- take
- raw material
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000282326 Felis catus Species 0.000 title claims abstract description 37
- 239000006187 pill Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 206010023644 Lacrimation increased Diseases 0.000 title abstract 2
- 230000004317 lacrimation Effects 0.000 title abstract 2
- 230000008961 swelling Effects 0.000 title abstract 2
- 241000972773 Aulopiformes Species 0.000 claims abstract description 23
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 20
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 13
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 13
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 12
- 241000272525 Anas platyrhynchos Species 0.000 claims abstract description 11
- 241000899834 Obovaria olivaria Species 0.000 claims abstract description 11
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 11
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 11
- 239000001527 calcium lactate Substances 0.000 claims abstract description 11
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 11
- 239000003862 glucocorticoid Substances 0.000 claims abstract description 11
- 235000008390 olive oil Nutrition 0.000 claims abstract description 11
- 239000004006 olive oil Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 239000003921 oil Substances 0.000 claims abstract description 10
- 235000019198 oils Nutrition 0.000 claims abstract description 10
- 229960003080 taurine Drugs 0.000 claims abstract description 10
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 9
- 239000005017 polysaccharide Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 15
- 241001290564 Fimbristylis Species 0.000 claims description 11
- 241000221377 Auricularia Species 0.000 claims description 10
- 244000173297 Medicago polymorpha Species 0.000 claims description 10
- 235000017823 Medicago polymorpha Nutrition 0.000 claims description 10
- 244000134552 Plantago ovata Species 0.000 claims description 10
- 235000003421 Plantago ovata Nutrition 0.000 claims description 10
- 239000009223 Psyllium Substances 0.000 claims description 10
- 230000018044 dehydration Effects 0.000 claims description 10
- 238000006297 dehydration reaction Methods 0.000 claims description 10
- 229940070687 psyllium Drugs 0.000 claims description 10
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 150000004676 glycans Chemical class 0.000 claims description 8
- 229960003722 doxycycline Drugs 0.000 claims description 5
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- -1 malt polysaccharide Chemical class 0.000 abstract description 2
- 235000019515 salmon Nutrition 0.000 abstract 2
- 244000000626 Daucus carota Species 0.000 abstract 1
- 235000002767 Daucus carota Nutrition 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 244000046070 Medicago sativa subsp falcata Species 0.000 abstract 1
- 235000010621 Medicago sativa subsp falcata Nutrition 0.000 abstract 1
- 244000090599 Plantago psyllium Species 0.000 abstract 1
- 235000010451 Plantago psyllium Nutrition 0.000 abstract 1
- 240000005893 Pteridium aquilinum Species 0.000 abstract 1
- 235000009936 Pteridium aquilinum Nutrition 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 239000010903 husk Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000010446 mirabilite Substances 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 230000002467 anti-pepsin effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000018931 inflamed eyes Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 150000004666 short chain fatty acids Chemical group 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
本发明涉及一种猫流泪红肿药丸及其制备方法,按质量份数包括:黄花苜蓿20‑30份、橄榄油10‑15份、鸭油10‑15份、三文鱼骨10‑15份、三文鱼鳞5‑10份、蕨菜5‑10份、黑木耳5‑10份、洋车前子壳粉5‑10份、枯草芽孢杆菌3‑6份、乳酸钙1‑1.5份、麦芽多糖2‑5份、牛磺酸2‑5份、山核桃外果皮5‑8份、芒硝2‑2.5份、胡萝卜2‑2.5份、糖皮质激素5‑8份、多西环素3‑5份。
Description
技术领域
本发明涉及一种猫流泪红肿药丸及其制备方法。
背景技术
猫咪是爱干净的动物,只要闲暇都会用舌头舔毛梳理,毛发和其上的赃物被吃进肚中,肚内毛发积累成毛球,不能消化,影响猫咪的健康。传统使用的食用植物油、鱼肝油的方法会增加猫咪的厌食、恶心感,而现有市场上的化毛膏大都含有化学添加剂、防腐剂、对猫咪的健康同样存在影响。猫在厌食同时,眼睛开始有眼屎、伴随红肿流泪现象产生。
发明内容
本发明提供了一种纯生物制备、无化学添加,增加猫咪口感和食欲、有效治疗猫咪流泪红肿的猫流泪红肿药丸及其制备方法。
本发明采用的技术方案是:一种猫流泪红肿药丸,其特征在于:按质量份数包括:黄花苜蓿20-30份、橄榄油10-15份、鸭油10-15份、三文鱼骨10-15份、三文鱼鳞5-10份、蕨菜5-10份、黑木耳5-10份、洋车前子壳粉5-10份、枯草芽孢杆菌3-6份、乳酸钙1-1.5份、麦芽多糖2-5份、牛磺酸2-5份、山核桃外果皮5-8份、芒硝2-2.5份、胡萝卜2-2.5份、糖皮质激素5-8份、多西环素3-5份。
一种猫流泪红肿药丸的制备方法,其特征在于:包括以下步骤,
(1)、取黄花苜蓿20-30份、蕨菜5-10份、黑木耳5-10份冻干脱水,脱水率85-90%,低温超微;
(2)、取三文鱼骨10-15份、三文鱼鳞5-10份烘干,含水率75-85%,粉碎100-150目;
(3)、取山核桃外果皮5-8份加入乙醇进行乙醇回流提取,滤液冷藏静置,取上清液备用;
(4)、取芒硝2-2.5份、胡萝卜2-2.5份加水没过煮透,滤取上清液备用;
(5)、将步骤(3)、(4)加入洋车前子壳粉5-10份、牛磺酸2-5份、麦芽多糖2-5份、乳酸钙1-1.5份,混合超低温浓缩,至60-80℃时相对密度为1.05-1.20的清膏;
(6)、将步骤(1)原料加橄榄油10-15份、鸭油10-15份混合,二次均质,第一次60-65℃、5-10MPa,第二次50-60℃、10-15MPa;
(7)、将步骤(6)原料中依次加入步骤(2)原料、枯草芽孢杆菌3-6份、糖皮质激素5-8份、多西环素3-5份和步骤(5)的清膏,混合搅拌均匀上烘干造粒机制成3-5mm颗粒,分装,即得。
本发明的优点是:采用枯草芽孢杆菌菌体能自身合成消化性酶类,在消化道中与内源酶共同发挥作用,提高猫咪肠胃蠕动及其消化率,同事枯草芽孢杆菌能合成多种维生素,提高猫咪体内干扰素和巨噬细胞的活性;三文鱼骨、鳞富含欧米伽3脂肪酸、亚油酸、亚麻酸、花生四烯酸,欧米伽3脂肪酸有助减少腺体炎症,有益甲状腺健康,确保猫咪的甲状腺激素正常调节,有效避免猫咪的肥胖,延长猫咪寿命,同时花生四烯酸属Omega6族长链多元不饱和脂肪酸,有效抗消化性溃疡及胃肠功能障碍,促进猫咪肠胃消化功能,三文鱼鳞富含不饱和脂肪酸卵磷脂,能有效提高猫咪毛发亮度和防止掉毛,从根源上解决猫咪舔舐毛发导致的毛球现象;洋车前子壳粉中纤维含量占80%,洋车前子纤维主要由半纤维素组成,可以在猫咪肠内部分分解,并有益于肠内益生菌,同时具有降低血胆固醇的功效。在肠内益生菌的作用下,洋车前子纤维中的糖类物质经发酵分解为短链脂肪酸(Short Chain FattyAcids),从而阻止胆固醇的合成,进一步提高防止猫咪肥胖的效果;枯草芽孢杆菌能速消耗肠道中的游离氧,造成肠道低氧,促进有益厌氧菌生长,并产生乳酸等有机酸类,降低肠道PH值,间接抑制其它致病菌生长,同时枯草芽孢杆菌蛋白酶能对猫咪毛发中的角蛋白产生降解作用,防止猫咪体内毛球过大,无法排出,有效降解毛发;采用芒硝和胡萝卜制作中间药液,促进猫咪肠胃消化,有利于猫咪的毛球排出,胡萝卜中富含的核黄素维生素B2能有效促进毛发生长,增强毛发韧性,避免猫咪舔舐掉落;山核桃外果皮中大黄酚有效促进猫咪肠道蠕动,其中没食子酸、槲皮素有效提高膏药的抗氧化性能,无需添加化学添加剂、防腐剂,有利于健康食用。黄花苜蓿功用利大小肠,安中,和胃;蕨菜中的纤维素可有促进肠道蠕动,减少肠胃对脂肪吸收的作用,蕨菜配合黑木耳,能有效清涤胃肠,消化纤维素,避免纤维素在猫咪肠胃内堆积,协同促进毛球排出和肠胃功能改善;使用橄榄油,可以促进消化吸收率,含有丰富的不饱和脂肪酸,丰富的维生素A、D、E、F、K和胡萝卜素等脂溶性维生素及抗氧化物等多种成分,并且不含胆固醇,可以刺激胆汁分泌,确保猫咪的排便正常,结合动物脂肪鸭油有效润肠,进一步提高毛球排便效果;乳酸钙配合三文鱼骨含钙,乳酸钙协同其他钙类容易被吸收,进一步促进猫咪的钙吸收。糖皮质激素起抑制免疫和抗炎作用的药物,配合多西环素免疫调节化合物防止眼睛红肿流泪感染。
具体实施方式
以下结合实施例对本发明作进一步说明。
实施例1:
一种猫流泪红肿药丸,按质量份数包括:黄花苜蓿20份、橄榄油10份、鸭油10份、三文鱼骨10份、三文鱼鳞5份、蕨菜5份、黑木耳5份、洋车前子壳粉5份、枯草芽孢杆菌3份、乳酸钙1份、麦芽多糖2份、牛磺酸2份、山核桃外果皮5份、芒硝2份、胡萝卜2份、糖皮质激素5份、多西环素3份。
一种猫流泪红肿药丸的制备方法,包括以下步骤,
(1)、取黄花苜蓿20份、蕨菜5份、黑木耳5份冻干脱水,脱水率85-90%,低温超微;
(2)、取三文鱼骨10份、三文鱼鳞5份烘干,含水率75%,粉碎100目;
(3)、取山核桃外果皮5份加入乙醇进行乙醇回流提取,滤液冷藏静置,取上清液备用;
(4)、取芒硝2份、胡萝卜2份加双倍重量的水没过煮透,滤取上清液备用;
(5)、将步骤(3)、(4)加入洋车前子壳粉5份、牛磺酸2份、麦芽多糖2份、乳酸钙1份,混合超低温浓缩,至60℃时相对密度为1.05的清膏;
(6)、将步骤(1)原料加橄榄油10份、鸭油10份混合,二次均质,第一次60℃、5MPa,第二次50℃、10MPa;
(7)、将步骤(6)原料中依次加入步骤(2)原料、枯草芽孢杆菌3份、糖皮质激素5份、多西环素3份和步骤(5)的清膏,混合搅拌均匀上烘干造粒机制成3-5mm颗粒,分装,即得。
实施例2:
一种猫流泪红肿药丸,按质量份数包括:黄花苜蓿30份、橄榄油15份、鸭油15份、三文鱼骨15份、三文鱼鳞10份、蕨菜10份、黑木耳10份、洋车前子壳粉10份、枯草芽孢杆菌6份、乳酸钙1.5份、麦芽多糖5份、牛磺酸5份、山核桃外果皮8份、芒硝2.5份、胡萝卜2.5份、糖皮质激素8份、多西环素5份。
一种猫流泪红肿药丸的制备方法,包括以下步骤,
(1)、取黄花苜蓿30份、蕨菜10份、黑木耳10份冻干脱水,脱水率90%,低温超微;
(2)、取三文鱼骨15份、三文鱼鳞10份烘干,含水率85%,粉碎150目;
(3)、取山核桃外果皮8份加入乙醇进行乙醇回流提取,滤液冷藏静置,取上清液备用;
(4)、取芒硝2.5份、胡萝卜2.5份加双倍重量的水没过煮透,滤取上清液备用;
(5)、将步骤(3)、(4)加入洋车前子壳粉10份、牛磺酸5份、麦芽多糖5份、乳酸钙1.5份,混合超低温浓缩,至80℃时相对密度为1.20的清膏;
(6)、将步骤(1)原料加橄榄油15份、鸭油15份混合,二次均质,第一次65℃、10MPa,第二次60℃、15MPa;
(7)、将步骤(6)原料中依次加入步骤(2)原料、枯草芽孢杆菌6份、、糖皮质激素8份、多西环素5份和步骤(5)的清膏,混合搅拌均匀上烘干造粒机制成3-5mm颗粒,分装,即得。
实施例3:
一种猫流泪红肿药丸,按质量份数包括:黄花苜蓿25份、橄榄油12份、鸭油13份、三文鱼骨13份、三文鱼鳞8份、蕨菜8份、黑木耳7份、洋车前子壳粉6份、枯草芽孢杆菌4份、乳酸钙1.2份、麦芽多糖3份、牛磺酸3份、山核桃外果皮6份、芒硝2.3份、胡萝卜2.2份、糖皮质激素6份、多西环素4份。
一种猫流泪红肿药丸的制备方法,包括以下步骤,
(1)、取黄花苜蓿25份、蕨菜8份、黑木耳7份冻干脱水,脱水率85-90%,低温超微;
(2)、取三文鱼骨135份、三文鱼鳞8份烘干,含水率80%,粉碎120目;
(3)、取山核桃外果皮6份加入乙醇进行乙醇回流提取,滤液冷藏静置,取上清液备用;
(4)、取芒硝2.3份、胡萝卜2.2份加双倍重量的水没过煮透,滤取上清液备用;
(5)、将步骤(3)、(4)加入洋车前子壳粉6份、牛磺酸3份、麦芽多糖3份、乳酸钙1.2份,混合超低温浓缩,至70℃时相对密度为1.1的清膏;
(6)、将步骤(1)原料加橄榄油12份、鸭油13份混合,二次均质,第一次62℃、8MPa,第二次55℃、13MPa;
(7)、将步骤(6)原料中依次加入步骤(2)原料、枯草芽孢杆菌4份、糖皮质激素6份、多西环素4份和步骤(5)的清膏,混合搅拌均匀上烘干造粒机制成3-5mm颗粒,分装,即得。
Claims (1)
1.一种猫流泪红肿药丸的制备方法,其特征在于:包括以下步骤,
(1)、取黄花苜蓿20-30份、蕨菜5-10份、黑木耳5-10份冻干脱水,脱水率85-90%,低温超微;
(2)、取三文鱼骨10-15份、三文鱼鳞5-10份烘干,含水率75-85%,粉碎100-150目;
(3)、取山核桃外果皮5-8份加入乙醇进行乙醇回流提取,滤液冷藏静置,取上清液备用;
(4)、取芒硝2-2.5份、胡萝卜2-2.5份加水没过煮透,滤取上清液备用;
(5)、将步骤(3)、(4)加入洋车前子壳粉5-10份、牛磺酸2-5份、麦芽多糖2-5份、乳酸钙1-1.5份,混合超低温浓缩,至60-80℃时相对密度为1.05-1.20的清膏;
(6)、将步骤(1)原料加橄榄油10-15份、鸭油10-15份混合,二次均质,第一次60-65℃、5-10MPa,第二次50-60℃、10-15MPa;
(7)、将步骤(6)原料中依次加入步骤(2)原料、枯草芽孢杆菌3-6份、糖皮质激素5-8份、多西环素3-5份和步骤(5)的清膏,混合搅拌均匀上烘干造粒机制成3-5mm颗粒,分装,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611157398.5A CN106668030A (zh) | 2016-12-15 | 2016-12-15 | 一种猫流泪红肿药丸的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611157398.5A CN106668030A (zh) | 2016-12-15 | 2016-12-15 | 一种猫流泪红肿药丸的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106668030A true CN106668030A (zh) | 2017-05-17 |
Family
ID=58869125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611157398.5A Pending CN106668030A (zh) | 2016-12-15 | 2016-12-15 | 一种猫流泪红肿药丸的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106668030A (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1442075A (zh) * | 2003-04-09 | 2003-09-17 | 李浙烽 | 一种饲料添加剂 |
CN1833531A (zh) * | 2006-03-04 | 2006-09-20 | 广西金禾生物科技连锁有限公司 | 一种中草药复合氨基酸饲料添加剂 |
CN101133812A (zh) * | 2007-10-10 | 2008-03-05 | 徐大军 | 一种超微蕨根粉及其生产工艺 |
CN101744962A (zh) * | 2008-12-22 | 2010-06-23 | 许巧 | 一种润肠通便保健食品配方 |
CN102028120A (zh) * | 2010-12-08 | 2011-04-27 | 蓬莱京鲁渔业有限公司 | 一种宠物食品及其制备方法 |
CN103997903A (zh) * | 2011-12-29 | 2014-08-20 | 希尔氏宠物营养品公司 | 用于改善胃肠菌群的组合物和方法 |
CN104198666A (zh) * | 2014-09-15 | 2014-12-10 | 黑龙江省科学院微生物研究所 | 一种木耳品质的多参数综合评价方法 |
CN104286476A (zh) * | 2014-09-26 | 2015-01-21 | 胡伟东 | 一种宠物猫专用饲料及其制备方法 |
-
2016
- 2016-12-15 CN CN201611157398.5A patent/CN106668030A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1442075A (zh) * | 2003-04-09 | 2003-09-17 | 李浙烽 | 一种饲料添加剂 |
CN1833531A (zh) * | 2006-03-04 | 2006-09-20 | 广西金禾生物科技连锁有限公司 | 一种中草药复合氨基酸饲料添加剂 |
CN101133812A (zh) * | 2007-10-10 | 2008-03-05 | 徐大军 | 一种超微蕨根粉及其生产工艺 |
CN101744962A (zh) * | 2008-12-22 | 2010-06-23 | 许巧 | 一种润肠通便保健食品配方 |
CN102028120A (zh) * | 2010-12-08 | 2011-04-27 | 蓬莱京鲁渔业有限公司 | 一种宠物食品及其制备方法 |
CN103997903A (zh) * | 2011-12-29 | 2014-08-20 | 希尔氏宠物营养品公司 | 用于改善胃肠菌群的组合物和方法 |
CN104198666A (zh) * | 2014-09-15 | 2014-12-10 | 黑龙江省科学院微生物研究所 | 一种木耳品质的多参数综合评价方法 |
CN104286476A (zh) * | 2014-09-26 | 2015-01-21 | 胡伟东 | 一种宠物猫专用饲料及其制备方法 |
Non-Patent Citations (1)
Title |
---|
陆冰等: "山核桃外果皮化学成分分析及应用研究进展", 《浙江林业科技》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102754753B (zh) | 用于改善肉仔鸡生长性能的饲料及其制备方法 | |
CN103564176B (zh) | 一种猪饲料及其制备方法 | |
CN105124230A (zh) | 湖羊饲料及其生产方法 | |
CN103609899B (zh) | 猪用抗腹泻促生长绿色饲料添加剂及其制备方法 | |
CN1919043A (zh) | 一种鸡饲料添加剂 | |
CN106259175A (zh) | 一种陆川仔猪的养殖方法 | |
CN105581045A (zh) | 一种改善仔猪肠道健康的饲料添加剂及其制备方法 | |
JP2018519337A (ja) | 便秘及び疲労回復の改善機能を有する発酵ミネラル生食丸剤の製造方法及びこれにより製造された発酵ミネラル生食丸剤 | |
CN105010832A (zh) | 小猪饲料的二次熟化生产方法 | |
CN112535245A (zh) | 一种鱼饲料及其生产方法 | |
CN107594160A (zh) | 一种具有保健功能的犊牛开食料饲料及其制备方法 | |
CN110122680A (zh) | 一种添加牛至精油降低奶牛乳房炎发病率饲料的制备方法 | |
CN112205535A (zh) | 一种益于肥胖型绝育猫减肥的营养专用粮及其制备方法 | |
CN107691785A (zh) | 一种含植物提取物的饲料添加剂及其制备方法与应用 | |
CN106581181A (zh) | 一种预防流目红肿猫粮的制备方法 | |
CN106666170A (zh) | 一种幼猫化毛膏的制备方法 | |
CN106689767A (zh) | 一种防结石猫粮的制备方法 | |
CN107173599A (zh) | 一种减轻仔猪断奶综合征的饲料添加剂及其制备方法与应用 | |
CN106942148A (zh) | 一种三黄鸡育成期养殖方法 | |
CN115997846A (zh) | 一种妊娠母猪促繁殖功能性营养组合物及其制备方法和应用 | |
CN106668030A (zh) | 一种猫流泪红肿药丸的制备方法 | |
CN106666168A (zh) | 一种防软骨猫粮的制备方法 | |
CN106689765A (zh) | 一种幼猫化毛膏 | |
CN106720943A (zh) | 一种驱虫化毛膏的制备方法 | |
CN106615882A (zh) | 一种幼猫化毛膏的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170517 |
|
WD01 | Invention patent application deemed withdrawn after publication |